• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGFA HEALTHCARE CORP IMPAX CV OUTBOUND (RESULTS MANAGEMETN 2.08); PICTURE ARCHIVING AND COMMUNCAIOTN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGFA HEALTHCARE CORP IMPAX CV OUTBOUND (RESULTS MANAGEMETN 2.08); PICTURE ARCHIVING AND COMMUNCAIOTN Back to Search Results
Model Number IMPAX CV 2.08
Device Problem Installation-Related Problem (2965)
Patient Problem No Information (3190)
Event Date 10/31/2014
Event Type  malfunction  
Event Description
Agfa submitted mdr report# 1225058-2010-00001 to the fda on june 7, 2010 for a site in the us.A 14th occurrence is being reported for the same issue/same device: impax cv results management administration tool (rmat).This is an internal discovery determined during the implementation of the associated problem correction plan, rmat verification, as reported in fda z-2112-10.
 
Manufacturer Narrative
An agfa clinical analyst performed a retro-analysis and reported the findings to agfa service and agfa product quality manager.Agfa's investigation into this occurrence of rmat customizations has revealed that this specific change had the potential to introduce clinical inaccuracies in pt reports.Specifically: the original sentence finding of "there is evidence of a tricuspid valve abscess" has been changed to: "the masses associated with the tricuspid valve are sessile".The original sentence indicates the presence of an abscess on the tb.The changed sentence changes the abscess to multiple sessile masses which are clinically different.Potential impact: if the change was made after reports had been generated with the original sentence selected, those reports prior to the change could display incorrect clinical data if viewed in rm or if used as a template for a repeat study on that pt.As soon as agfa is made aware of any affected reports related to this specific finding, follow-up mdrs will be submitted for each associated study date and respective medical record number/s (mrn) identified.There has been no reported pt harm for this occurrence.A reportable correction is underway for this issue and has been reported to the fda via reference # z-2112-10.Agfa will follow the rmat post market verification work instructions to correct the sentence finding.Any further investigation for the site described in this report will be document in the ongoing cfr part 806 reporting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPAX CV OUTBOUND (RESULTS MANAGEMETN 2.08)
Type of Device
PICTURE ARCHIVING AND COMMUNCAIOTN
Manufacturer (Section D)
AGFA HEALTHCARE CORP
1 crosswind rd
misquamicut RI 02891
Manufacturer Contact
deborah huff
10 south academy street
greenville, SC 29601
8644211754
MDR Report Key4293354
MDR Text Key5055593
Report Number1225058-2014-06319
Device Sequence Number1
Product Code LLZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K050228
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Remedial Action Other
Type of Report Initial
Report Date 11/24/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberIMPAX CV 2.08
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/31/2014
Initial Date FDA Received11/24/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2002
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-